Recruiting

Observational Study

Sponsor:

Sanguine Biosciences

Code:

NCT05669105

Conditions

Non Small Cell Lung Cancer

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Specimen sample

Study Details

Brief summary:

The study objective is to collect biospecimen samples (e.g., whole blood) from participants diagnosed with active lung cancer to investigate the immune response to develop treatments and therapies.

Conditions

Non Small Cell Lung Cancer

Study ID

NCT05669105

Start date

Feb 19, 2022

Status verified date

Nov, 2023

Completion date

Mar 31, 2024

Anticipated

Primary completion date

Mar 31, 2024

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • Participants willing and able to provide written informed consent
  • Participants are willing and able to provide appropriate photo identification
  • Participant's age 18 - 100 years old
  • Participants diagnosed with active non-small cell lung cancer (Adenocarcinoma or Squamous Cell only. All stages are acceptable.)
  • Participants must have associated tissue biomarker data (EFGR and MET mutations) in their medical records

Exclusion Criteria:

  • Participants who are pregnant or nursing
  • Participants with a known history of HIV, hepatitis, or other infectious diseases
  • Participants who have taken an investigational product in the last 30 days
  • Participants who have experienced excess blood loss, including blood donation defined as 250 mL in the last month or 500 mL in the previous two months
  • Participants currently enrolled in a clinical trial
  • Participants currently in remission

Study Design

Enrollment

200 participants

Anticipated

Interventions and Outcome Measures

Interventions

Specimen sample

Participants will have up to 100 mL of whole blood collected.

Primary outcome measure

  • Biospecimen & Clinical Data Collection [ Time Frame: 10 years ]

Central Contacts and Locations

Central contacts

Thomas Goslin

(818) 583-8844tgoslin@sanguinebio.com

Locations

Sanguine Biosciences

Recruiting

Waltham, Massachusetts, United States, 02451

Contacts

Thomas Goslin

818-583-8844tgoslin@sanguinebio.com

Principal Investigator:

Houman Hemmati, MD

More Information

Sponsor

Sanguine Biosciences

Last update posted

Nov 22, 2023

Last verified

Nov, 2023

Keywords

  • lung cancer
  • NSCLC

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Sanguine Biosciences on 2023-11-22.